insights_auto
Why is NBIX down 4,41%?
Dive Deeperchevron_right
NBIX:NASDAQ
Neurocrine Biosciences, Inc
135,13 US$
arrow_downward
-4,41%(-6,24) 1D
135,50 US$
arrow_upward
+0,27% (+0,37)bedtimeAfter hours
Closed: 13 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NBIX...
Open
139,60 US$
High
139,92 US$
Low
134,89 US$
Mkt. cap
13,74 მლრდ.
Avg. vol.
1,30 მლნ.
Volume
1,57 მლნ.
P/E ratio
19,81
52-wk high
186,12 US$
52-wk low
122,14 US$
EPS
6,82 US$
Beta
0,40
Shares outstanding
101,65 მლნ.
No. of employees
2 ათ.
Open
139,60 US$
High
139,92 US$
Low
134,89 US$
Mkt. cap
13,74 მლრდ.
Avg. vol.
1,30 მლნ.
Volume
1,57 მლნ.
P/E ratio
19,81
52-wk high
186,12 US$
52-wk low
122,14 US$
EPS
6,82 US$
Beta
0,40
Shares outstanding
101,65 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
Barron's
·
2 საათის წინ
This Biopharma Stock Offers Compelling Upside After a Pullback
GuruFocus
·
4 საათის წინ
Is Neurocrine Biosciences Inc (NBIX) a Bargain After 4.4% Drop? GF Value Says Undervalued
Insider Monkey
·
9 საათის წინ
Axsome Therapeutics (AXSM) vs. Neurocrine Biosciences (NBIX): Is Faster Growth Worth Paying More For?
Zacks
·
11 საათის წინ
NBIX vs. SDZNY: Which Stock Should Value Investors Buy Now?
Profile
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. It is headquartered in San Diego, California, and led by CEO Kyle Gano as of October 11, 2024. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine was approved in the US to treat adults with tardive dyskinesia.
The company is also developing treatments that are in various stages of clinical research for Parkinson's disease, Tourette syndrome, and congenital adrenal hyperplasia and with a partner for endometriosis and uterine fibroids. Wikipedia
About Neurocrine Biosciences, Inc
CEOკევინ სი გორმან
Employees2,5 ათ.
Founded1992
Headquartersსან-დიეგო, კალიფორნია, ამერიკის შეერთებული შტატები
Sector-
Websiteneurocrine.com